Decagon Asset Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Decagon Asset Management’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Hold	162,702	–	–	0.03%	64
2026 Q1	$122K	Buy	162,702 +15,200	+10%	+$11.9K	0.03%	42
2025 Q4	$105K	Sell	147,502 -45,122	-23%	-$37.7K	0.04%	32
2025 Q3	$144K	Buy	192,624 +7,877	+4%	+$6.37K	0.07%	34
2025 Q2	$162K	Buy	184,747 +3,305	+2%	+$2.55K	0.11%	29
2025 Q1	$136K	Sell	181,442 -544	-0.3%	-$413	0.1%	26
2024 Q4	$160K	Buy	+181,986	New	+$119K	0.07%	24

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Decagon Asset Management's OACCW Position: Q2 2026 in Review

Decagon Asset Management held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q2 2026 at 162,702 shares worth $153K. The position accounts for 0.03% of the portfolio, ranked #64.

Decagon Asset Management first reported a position in OACCW in Q4 2024 and has held it in 7 quarters since. The position peaked at $162K in Q2 2025. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

Decagon Asset Management held 162,702 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $153K as of Q2 2026.
Decagon Asset Management left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences Warrant made up 0.03% of Decagon Asset Management's portfolio in Q2 2026, its #64 holding.
Decagon Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 7 quarters since.
Decagon Asset Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $162K in Q2 2025.
27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Decagon Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.